From The Floor At CPHI 2025: Takeaways Everyone Should Know

J.D. Mowery, President of Bora CDMO, shares key insights from CPHI Worldwide 2025, one of the industry’s most influential global events. His perspective highlights how priorities are shifting toward collaboration, supply chain resilience, and advanced manufacturing technologies that enable greater agility.

Mowery emphasizes the growing demand for flexible, scalable solutions that help pharmaceutical companies adapt quickly to regulatory changes and evolving market needs. He notes that partners increasingly seek CDMOs with deep technical expertise and the ability to guide complex development pathways from early formulation through commercial launch.

The discussion also underscores how global forums like CPHI foster partnerships, encourage knowledge sharing, and spotlight emerging technologies shaping the future of drug development and manufacturing. For professionals, investors, and industry observers, these insights provide a clear view of where the market is headed and what capabilities will define success in 2025.